e8vk
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 30, 2007
THORATEC CORPORATION
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
California
(State or other jurisdiction
of incorporation)
|
|
000-49798
(Commission file number)
|
|
94-2340464
(I.R.S. Employer
Identification Number) |
| |
|
|
6035 Stoneridge Drive
Pleasanton, California
(Address of principal executive offices)
|
|
94588
(Zip Code) |
Registrant’s telephone number, including area code: (925) 847-8600
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
| |
|
|
o
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
o
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) |
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |
Item 8.01. Other Events.
On March 30, 2007, Thoratec Corporation (the “Company”) filed its Annual Report on Form 10-K
for the year ended December 30, 2006 (“2006 10-K”)
after completing a detailed review of
its equity-based compensation practices, including a review of the underlying documentation and
procedures, and related accounting, for such practices. On
April 2, 2007, the Company issued a
press release, which is filed herewith as Exhibit 99.1, concerning the filing of the 2006 10-K and
related matters.
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits
| |
|
|
|
|
| Exhibit |
|
Description |
|
|
|
|
|
|
|
| 99.1 |
|
Press Release of
Thoratec Corporation, dated April 2, 2007. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated:
April 2, 2007
| |
|
|
|
|
| |
THORATEC CORPORATION
|
|
| |
By: |
/s/ David V. Smith
|
|
| |
|
David V. Smith |
|
| |
|
Executive Vice President and Chief Financial Officer |
|
EXHIBIT INDEX
| |
|
|
|
|
| Exhibit |
|
Description |
|
|
|
|
|
|
|
| 99.1 |
|
Press Release of
Thoratec Corporation, dated April 2, 2007. |